Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

FDA Approves Labeling Changes Including Boxed Warning For Immune Effector Cell-Associated Enterocolitis After Treatment With Ciltacabtagene Autoleucel; Determined Overall Benefit Of CARVYKTI Continues To Outweigh Potential Risks For Approved Use

Author: Benzinga Newsdesk | October 10, 2025 05:32pm

https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/fda-approves-labeling-changes-include-boxed-warning-immune-effector-cell-associated-enterocolitis

Posted In: JNJ

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist